Palatin Technologies
PTN
#10644
Rank
NZ$24.72 M
Marketcap
NZ$13.90
Share price
-1.42%
Change (1 day)
N/A
Change (1 year)

Palatin Technologies (PTN) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$0.49 Million

According to Palatin Technologies's latest financial reports the company's total debt is NZ$0.49 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Palatin Technologies - Total debt on balance sheet (from 1997 to 2026)

Total debt by year

Year Total debt Change
2025-06-30NZ$0.26 M-72.23%
2024-06-30NZ$0.96 M-43.5%
2023-06-30NZ$1.71 M-7.35%
2022-06-30NZ$1.84 M3.3%
2021-06-30NZ$1.78 M-8.8%
2020-06-30NZ$1.96 M296.38%
2019-06-30NZ$0.49 M-94.66%
2018-06-30NZ$9.27 M-51.91%
2017-06-30NZ$19.28 M-29.5%
2016-06-30NZ$27.35 M88.53%
2015-06-30NZ$14.51 M
2014-06-30N/A-100%
2013-06-30NZ$0.02 M-51.05%
2012-06-30NZ$0.05 M-43.53%
2011-06-30NZ$0.09 M89.63%
2010-06-30NZ$0.04 M-74.13%
2009-06-30NZ$0.18 M-62.49%
2008-06-30NZ$0.5 M-20.97%
2007-06-30NZ$0.63 M22.6%
2006-06-30NZ$0.52 M1082.15%
2005-06-30NZ$0.04 M-55.66%
2004-06-30NZ$0.09 M-78.08%
2003-06-30NZ$0.45 M
2001-06-30NZ$0.06 M
1999-06-30NZ$3.77 M118.27%
1998-06-30NZ$1.73 M-34.71%
1997-06-30NZ$2.65 M-44.25%
1996-06-30NZ$4.75 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$95.10 B 19,181,723.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$58.66 B 11,831,953.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$0.70 B 141,599.98%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ$0.28 M-42.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.78 B 157,568.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$1.06 B 214,005.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.36 B 72,551.42%๐Ÿ‡บ๐Ÿ‡ธ USA